Clinical Trials for Mesothelioma Patients: Cisplatin, Imatinib Mesylate, and Pemetrexed Study
Read about a current clinical trial study being conducted to study the effects of Cisplatin, Imatinib Mesylate, and Pemetrexed or patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. At this time, this study is only being conducted in Lille, France.
Requisite Conditions:
Mesothelioma
Interventions:
Drugs: Cisplatin; Imatinib Mesylate; PemetrexedStudy Phase, Type and Design:
Phase I Interventional; Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title:
Phase I Trial of Cisplatin, Pemetrexed, and Imatinib Mesylate in Unresectable or Metastatic Malignant Mesothelioma
Courtesy of a service of the U.S. National Institutes of Health
Other helpful links:
Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney
Inclusion criteria to treat mesothelioma patients with Imatinib